DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox Cosmetic (Botulinum Toxin Type A) - Published Studies

 
 



Botox Cosmetic Related Published Studies

Well-designed clinical trials related to Botox Cosmetic (Botulinum Toxin Type A)

A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. [2015]

The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines. [2015]

The early use of botulinum toxin in post-stroke spasticity: study protocol for a randomised controlled trial. [2014]

Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study. [2014]

Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study. [2014]

Botulinum toxin to improve results in cleft lip repair. [2014]

Botulinum toxin a does not decrease calf pain or improve ROM during limb lengthening: a randomized trial. [2014]

Safety and efficacy of botulinum toxin in primary orthostatic tremor. [2013]

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. [2013]

Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin. [2013]

Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. [2013]

Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study. [2013]

Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact. [2012]

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]

Botulinum toxin effects on gasatrocnemius strength and plantar pressure in diabetics with peripheral neuropathy and forefoot ulceration. [2012]

Modification of altered ankle motor control after stroke using focal application of botulinum toxin type A. [2012]

Vandetanib: in medullary thyroid cancer. [2012]

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. [2012]

Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA. [2012]

Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). [2012]

Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles. [2012]

Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial. [2012]

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer. [2011.09]

Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial. [2011.09]

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. [2011.08]

Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A. [2011.07]

Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. [2011.07]

Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. [2011.06]

[Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique]. [2011.05]

Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain. [2011.05]

Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. [2011.05]

Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. [2011.04]

Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial. [2011.03]

Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial. [2011.03]

Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. [2011.02.01]

Functional electrical stimulation combined with botulinum toxin type A to improve hand function in children with spastic hemiparesis - a pilot study. [2011.02]

Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study. [2011.02]

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. [2011.02]

A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. [2011.02]

[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [2011.01]

Prophylactic botulinum type A toxin complex (Dysport(R)) for migraine without aura. [2011.01]

A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. [2011.01]

Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study. [2011.01]

Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial. [2011]

Implications of current clinical trials focused on medication overuse and therapeutic prophylaxis. [2011]

Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A. [2011]

The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial. [2011]

Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. [2011]

[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [Article in French] [2011]

Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial. [2011]

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. [2011]

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis. [2011]

Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. [2010.12]

Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? [2010.12]

Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. [2010.12]

Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. [2010.12]

Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study. [2010.12]

Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. [2010.12]

Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. [2010.12]

A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem. [2010.12]

Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. [2010.12]

Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial. [2010.12]

Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. [2010.12]

Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. [2010.11]

Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial. [2010.11]

Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. [2010.11]

Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses. [2010.11]

Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. [2010.10]

Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. [2010.09]

The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. [2010.07]

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010.07]

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010.07]

A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. [2010.05]

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. [2010]

The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. [2010]

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010]

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010]

Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. [2010]

Botulinum toxin type A in post-stroke upper limb spasticity. [2010]

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. [2010]

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. [2010]

Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. [2010]

Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. [2010]

Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. [2010]

Supraciliary wrinkles and botulinum toxin A. [2010]

Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. [2010]

Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. [2009.10]

An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects. [2009.07]

Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method. [2009.05]

Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. [2009.05]

A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. [2009.03]

The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. [2008.12]

The effects of one botulinum toxin type A (BTX-A) injection after UPPP. [2008.10]

The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. [2008.08]

Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. [2007.11]

Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles. [2007.09]

A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type a in the treatment of lateral orbital rhytides. [2007.05]

A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides. [2007.04]

UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study. [2007.01]

Patient-reported outcomes with botulinum toxin type a treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. [2007.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017